| Mr Joseph R Dupper, DPM | |
|
2506 Danville Rd Sw Suite 204, Decatur, AL 35603 | |
| (256) 340-1500 | |
| (256) 340-1566 |
| Full Name | Mr Joseph R Dupper |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 31 Years |
| Location | 2506 Danville Rd Sw Suite 204, Decatur, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447326442 | NPI | - | NPPES |
| 07741 | Other | AL | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 158 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kajo Medical Pc | 2961712252 | 2 |
News Archive
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, announced today it has received an Israeli Patent for its Ultrapure Transferrin to be used in Pharmaceutical Compositions.
According to the agriculture ministry in Britain, a parrot has died in quarantine and has been found to have the lethal H5N1 strain of bird flu.
Kaiser Health News' Amita Parashar reports: "One of the most fundamental ideas in the new health law is that employers should offer health insurance to their workers, or else they would have to pay a penalty, beginning in 2014.
› Verified 2 days ago
| Provider Name | Kajo Medical Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1346612421 PECOS PAC ID: 2961712252 Enrollment ID: O20151117002871 |
News Archive
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, announced today it has received an Israeli Patent for its Ultrapure Transferrin to be used in Pharmaceutical Compositions.
According to the agriculture ministry in Britain, a parrot has died in quarantine and has been found to have the lethal H5N1 strain of bird flu.
Kaiser Health News' Amita Parashar reports: "One of the most fundamental ideas in the new health law is that employers should offer health insurance to their workers, or else they would have to pay a penalty, beginning in 2014.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Joseph R Dupper, DPM 2506 Danville Rd Sw Suite 204, Decatur, AL 35603 Ph: (256) 340-1500 | Mr Joseph R Dupper, DPM 2506 Danville Rd Sw Suite 204, Decatur, AL 35603 Ph: (256) 340-1500 |
News Archive
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, announced today it has received an Israeli Patent for its Ultrapure Transferrin to be used in Pharmaceutical Compositions.
According to the agriculture ministry in Britain, a parrot has died in quarantine and has been found to have the lethal H5N1 strain of bird flu.
Kaiser Health News' Amita Parashar reports: "One of the most fundamental ideas in the new health law is that employers should offer health insurance to their workers, or else they would have to pay a penalty, beginning in 2014.
› Verified 2 days ago
Dr. Matthew Nalamlieng, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1107 14th Ave Se Ste 300, Decatur, AL 35601 Phone: 256-350-0362 |